3种评分工具对缺血性卒中伴心房颤动患者1年死亡风险评估的验证

doi:10.3969/j.issn.1673-5765.2018.08.012

摘要/Abstract

摘要：

目的本文旨在通过对临床预后预测模型在中国伴心房颤动的缺血性脑血管病患者中的预测效度的评估，寻找能够准确预测预后结局的评分工具，更好地指导临床医疗决策。

方法从中国国家卒中登记（China National Stroke Registry，CNSR）研究中选取连续入组的缺血性卒中住院患者为本研究的研究人群。收集患者人口学信息、临床特点及用药信息等基本资料，随访时间为1年，预后结局包括卒中复发及死亡。用χ 2检验比较缺血性卒中伴或不伴心房颤动患者基线资料，P ＜0.01为差异具有统计学意义。采用C值表示的受试者工作特征曲线下面积（area under the curve，AUC）来评价缺血性卒中风险预测评分（ischemic stroke predictive risk score，IScore），住院前合并症、意识水平、年龄和局灶性神经功能缺损（preadmission comorbidities，level of consciousness，age，and neurologic deficit，PLAN）评分和洛桑卒中量表（acute stroke registry and analysis of Lausanne，ASTRAL）评分对 1年死亡风险的预测效度。按照各个评分的分层标准计算各层人群死亡和卒中复发的事件发生率。

结果从CNSR数据库中选取12 415例完成1年随访的缺血性卒中患者作为本研究的研究人群。其中，10 847例（87.37%）患者不伴心房颤动，1568例（12.63%）患者伴心房颤动。总研究人群1年全因死亡的事件发生率为13.4%，伴心房颤动患者的1年死亡率为34.6%，不伴心房颤动患者的1年死亡率为 10.3%。随着各评分分数的增高，死亡事件发生率逐渐增加。IScore对于伴心房颤动的缺血性卒中患者预测死亡的C值为0.784，PLAN评分为0.769，ASTRAL评分为0.793。

结论 IScore、PLAN评分和ASTRAL评分可针对1年死亡风险对缺血性卒中患者进行初步分层。各评分工具对于中国缺血性卒中伴心房颤动的患者1年死亡风险有较高的预测能力。

文章导读： IScore、PLAN评分和ASTRAL评分可对缺血性卒中伴心房颤动患者1年死亡风险进行初步分层，优化临床决策。

关键词: 缺血性卒中; 心房颤动; 风险评估; 危险因素

Abstract:

Objective To compare the predictive value of three scores tool for 1-year death risk in Chinese ischemic stroke patients with atrial fibrillation (AF), to find an optimal scale so as to provide guidance for making clinical decisions. Methods Patients with acute ischemic stroke (AIS) selected from China National Stroke Registry (CNSR) were divided into AF group and non-AF group. Demographic information, clinical characteristics and drug information were collected. The primary outcome was 1-year stroke recurrence and death. Using chi-square test to compare the baseline data of two groups. The predictive value of ischemic stroke predictive risk score (IScore), preadmission comorbidities, level of consciousness, age, and neurologic deficit (PLAN) score and acute stroke registry and analysis of Lausanne (ASTRAL) score for 1-year death risk of two groups were compared using C statistic (expressed by area under the curve). Results A total of 12 415 AIS patients who completed 1-year follow-up from CNSR were included in this study. Of all 12 415 patients, 10 847 (87.37%) were non-AF patients and 1568 (12.63%) were AF patients. The total 1-year all-cause mortality of all subjects was 13.4%, while the 1-year mortality of AF group and non-AF group were 34.6% and 10.3%, respectively. The risk of death increased with elevation of the scores. The C statistic of IScore, PLAN and ASTRAL scores predicting 1-year death risk for AIS patients with AF were 0.784, 0.769 and 0.793, respectively. Conclusions IScore, PLAN and ASTRAL scores could preliminarily stratify the risk of 1-year death for AIS patients with AF, and all three scores tool had a high predictive value of 1-year risk of death for such patients.

Key words: Ischemic stroke; Atrial fibrillation; Risk stratification; Risk factors

李姝雅, 赵性泉, 刘丽萍, 王春雪, 刘改芬, 王伊龙, 王拥军. 3种评分工具对缺血性卒中伴心房颤动患者1年死亡风险评估的验证[J]. 中国卒中杂志, 2018, 13(08): 818-822.

LI Shu-Ya, ZHAO Xing-Quan, LIU Li-Ping, WANG Chun-Xue, LIU Gai-Fen, WANG Yi-Long, WANG Yong-Jun. Validity Comparison of Three Scores Tool for 1-year Death Risk Assessment in Chinese Ischemic Stroke Patients with Atrial Fibrillation[J]. Chinese Journal of Stroke, 2018, 13(08): 818-822.

参考文献

[1] SAPOSNIK G，KAPRAL M K，LIU Y，et al.

IScore：a risk score to predict death early after

hospitalization for an acute ischemic stroke[J].

Circulation，2011，123（7）：739-749.

[2] O'DONNELL M J，FANG J，D'UVA C，et al. The

PLAN score：a bedside prediction rule for death and

severe disability following acute ischemic stroke[J].

Arch Intern Med，2012，172（20）：1548-1556.

[3] NTAIOS G，FAOUZI M，FERRARI J，et al. An

integer-based score to predict functional outcome in

acute ischemic stroke：the astral score[J]. Neurology，

2012，78（24）：1916-1922.

[4] ZHANG N，LIU G，ZHANG G，et al. External

validation of the iScore for predicting ischemic

stroke mortality in patients in China[J]. Stroke，2013，

44（7）：1924-1929.

[5] LIU G，NTAIOS G，ZHENG H，et al. External

validation of the ASTRAL score to predict 3- and

12-month functional outcome in the China National

急性缺血性卒中患者有21%～44%合并糖

尿病[11-12]。有研究将糖尿病与其他危险因素独

立存在视为卒中的重要危险因素，发现2型糖尿

病患者发生卒中的时间较非糖尿病患者要早10

年[13]。CNSR研究结果提示糖尿病是缺血性卒

中患者6个月死亡或致残的独立危险因素[14]。糖

尿病作为危险因素被纳入心房颤动患者卒中风

险分层工具[15-16]，本研究结果提示包括急性期

血糖升高的IScore和ASTRAL评分较未包括

血糖因素的PLAN评分整体预测能力稍高。

本研究存在一定局限性。首先，本研究验

证了3种评分工具，为达到研究人群的统一，全

部选用缺血性卒中患者作为研究人群，未纳入

短暂性脑缺血发作患者，所有患者未区分是否

接受抗血小板治疗，研究人群统一造成的对于

各评分风险分层的事件发生率及评分工具预测

能力的影响不可避免。其次，由于数据库中影

像学及分子标志物信息收集不全，导致影像学

及分子标志物相关的不良预后风险模型无法在

本研究中得到验证。

Stroke Registry[J]. Stroke，2013，44（5）：1443-1445.

[6] WANG Y，CUI L，JI X，et al. The China

National Stroke Registry for patients with acute

cerebrovascular events：design，rationale，and

baseline patient characteristics[J]. Int J Stroke，2011，

6（4）：355-361.

[7] DENG Y X，WANG Y L，GAO B Q，et al. Age

differences in clinical characteristics，health care，

and outcomes after ischemic stroke in China[J]. CNS

Neurosci Ther，2012，18（10）：819-826.

[8] FONAROW G C，REEVES M J，ZHAO X，et

al. Age-related differences in characteristics，

performance measures，treatment trends，and

outcomes in patients with ischemic stroke[J].

Circulation，2010，121（7）：879-891.

[9] SAPOSNIK G，BLACK S E，HAKIM A，et al. Age

disparities in stroke quality of care and delivery of

health services[J]. Stroke，2009，40（10）：3328-3335.

[10] Stroke Risk in Atrial Fibrillation Working Group.

Independent predictors of stroke in patients with

atrial fibrillation：a systematic review[J]. Neurology，

2007，69（6）：546-554.

[11] KERNAN W N，VISCOLI C M，INZUCCHI S

E，et al. Prevalence of abnormal glucose tolerance

following a transient ischemic attack or ischemic

stroke[J]. Arch Intern Med，2005，165（2）：227-233.

[12] MEGHERBI S E，MILAN C，MINIER D，et al.

Association between diabetes and stroke subtype

on survival and functional outcome 3 months after

stroke：data from the European BIOMED Stroke

Project[J]. Stroke，2003，34（3）：688-694.

[13] KANNEL W B，MCGEE D L. Diabetes and

cardiovascular disease. The Framingham study[J].

JAMA，1979，241（19）：2035-2038.

[14] JIA Q，ZHAO X，WANG C，et al. Diabetes and

poor outcomes within 6 months after acute ischemic

stroke：the China national stroke registry[J]. Stroke，

2011，42（10）：2758-2762.

[15] GAGE B F，WATERMAN A D，SHANNON W，et

al. Validation of clinical classification schemes for

predicting stroke：results from the national registry

of atrial fibrillation[J]. JAMA，2001，285（22）：

2864-2870.

[16] LIP G Y，NIEUWLAAT R，PISTERS R，et al.

Refining clinical risk stratification for predicting

stroke and thromboembolism in atrial fibrillation

using a novel risk factor-based approach：The euro

heart survey on atrial fibrillation[J]. Chest，2010，137

（2）：263-272.